Shu-shu Wang

In vivo and in vitro studies of Danzhi Jiangtang capsules against diabetic cardiomyopathy via TLR4/MyD88/NF-κB signaling pathway

Zhaohui Fang, Rui Song, Peng Zhou, 2021, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

Molecular docking and in vivo studies of liquiritin against acute myocardial infarction via TLR4/MyD88/NF-κB signaling

Peng Zhou, Shu-shu Wang, An-lu Shen, 2022, Italian Journal of Food Science.

Virtual screening analysis of natural flavonoids as trimethylamine (TMA)-lyase inhibitors for coronary heart disease.

Jin-Ling Huang, Peng Zhou, Shu-shu Wang, 2022, Journal of food biochemistry.

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity

G. Gao, Jian-fei Peng, Peng Zhou, 2022, Pharmaceutical biology.

Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF-κB signaling pathway.

Gang Yin, G. Gao, Peng Zhou, 2021, Journal of food biochemistry.

Punicalagin attenuates ventricular remodeling after acute myocardial infarction via regulating the NLRP3/caspase-1 pathway

Jian-fei Peng, Peng Zhou, Hui Shi, 2023, Pharmaceutical biology.